InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
T+90 hit rate
67%
T+90 mean return
+1.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Pinion John Richard, Executive. Insider active across 1 company, notably Ultragenyx Pharmaceutical Inc.. In total, 9 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €479k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 1 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
14,494 shares0Common StockSEC:0000950170-25-032785:0
17,800 shares0Common StockSEC:0000950170-24-026648:0
2,012 shares@ US$50.0019.5% of flowCommon StockSEC:0001209191-23-030931:0
2,663 shares0Common StockSEC:0001209191-23-016042:0
4,498 shares@ US$66.620.011% mcap69.3% of flowCommon StockSEC:0001209191-22-015823:0
358 shares@ US$81.145.2% of flowCommon StockSEC:0001209191-21-060748
358 shares@ US$81.140.0010% mcap6.5% of flowCommon StockSEC:0001209191-21-060748:0
363 shares@ US$113.698.9% of flowCommon StockSEC:0001209191-21-031387
363 shares@ US$113.690.0014% mcap8.9% of flowCommon StockSEC:0001209191-21-031387:0
9 of 9 declarations
About Pinion John Richard
John Richard Pinion is a key member of Ultragenyx Pharmaceutical Inc. While his specific role is not detailed, he contributes to the management and strategy of the company. His expertise in the pharmaceutical sector is essential for guiding strategic decisions and optimizing performance.
